Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6382.5000 -45.00 (-0.70%)
NSE Dec 29, 2025 15:14 PM
Volume: 196.8K
 

6382.50
-0.70%
Deven Choksey
Divi’s enters the second half of FY26 with a healthy execution pipeline across Custom Synthesis, supported by multiple projects progressing through validation and expected to commercialize over the next 1–2 years.
Divi's Laboratories Ltd. is trading above its 200 day SMA of 6292.1
More from Divi's Laboratories Ltd.
Recommended